XML 32 R23.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Restructuring, Impairment and Other Costs of Terminated Program (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Restructuring and Related Activities [Abstract] |
Schedule of Restructuring, Impairment and Other Costs of Terminated Program | Restructuring, impairment and other costs of terminated program includes the following (in thousands):
|  | Three Months Ended |  | Nine Months Ended
|  | September 30, 2022
Clinical trial expense, other third-party and employee costs for the wind down of the bempegaldesleukin program |  | $ | 8,530 |  |  | $ | 28,938 |
Severance and benefit expense |  | 2,077 |  |  | 29,827 |
Impairment of right-of-use assets and property, plant and equipment |  | 1,200 |  |  | 58,521 |
Contract termination and other restructuring costs |  | 5,023 |  |  | 7,064 |
Restructuring, impairment and other costs of terminated program |  | $ | 16,830 |  |  | $ | 124,350 |
The following table provides details regarding the severance and other termination benefit expense and a reconciliation of such liability for the three and nine months ended September 30, 2022, which we report within Accrued compensation on our Condensed Consolidated Balance Sheet (in thousands):
|  | Three and Nine Months Ended September 30, 2022
|  | No service period |  | Service period required |  | Total
Total severance and other termination benefits, at fair value |  | $ | 23,000 |  |  | $ | 7,955 |  |  | $ | 30,955 |
Liability balance as of March 31, 2022 |  | $ | — |  |  | $ | — |  |  | $ | — |
Expense recognized during the period |  | 23,588 |  |  | 4,162 |  |  | 27,750 |
Payments during the period |  | (12,881) |  |  | — |  |  | (12,881) |
Liability balance as of June 30, 2022 |  | $ | 10,707 |  |  | $ | 4,162 |  |  | $ | 14,869 |
Expense recognized during the period |  | (588) |  |  | 2,661 |  |  | 2,073 |
Payments during the period |  | (9,544) |  |  | (2,505) |  |  | (12,049) |
Liability balance as of September 30, 2022 |  | $ | 575 |  |  | $ | 4,318 |  |  | $ | 4,893 |
Additionally, we recorded an impairment expense primarily for software which we plan to abandon and certain excess equipment based on the estimated income from selling such assets, which we also present as assets held for sale in other current assets in our Condensed Consolidated Balance Sheet as of September 30, 2022. We recorded impairment charges as follows (in thousands):
| Nine Months Ended September 30, 2022
| Property, Plant and Equipment |  | Operating Lease Right-of-Use Assets |  | Total
Net book value of impaired facilities before write-off | $ | 16,348 |  |  | $ | 74,191 |  |  | $ | 90,539 |
Less: Fair value of impaired facilities — Level 3 of Fair Value Hierarchy | (6,976) |  |  | (30,162) |  |  | (37,138) |
Impairment expense for facilities | 9,372 |  |  | 44,029 |  |  | 53,401 |
Impairment of other property, plant and equipment | 5,120 |  |  | — |  |  | 5,120 |
Total impairment of right-of-use assets and property, plant and equipment | $ | 14,492 |  |  | $ | 44,029 |  |  | $ | 58,521 |
Schedule of Property, Plant and Equipment | The following table presents our property, plant and equipment as of September 30, 2022 and December 31, 2021, reflecting the effects of the impairment charges and held-for-sale reclassifications.
| September 30, 2022 |  | December 31, 2021
Building and leasehold improvements | $ | 78,380 |  |  | $ | 97,385 |
Laboratory equipment | 34,628 |  |  | 42,704 |
Computer equipment and software | 28,183 |  |  | 28,829 |
Manufacturing equipment | 23,779 |  |  | 22,374 |
Furniture, fixtures, and other | 4,647 |  |  | 10,094 |
Depreciable property, plant and equipment at cost | 169,617 |  |  | 201,386 |
Less: accumulated depreciation | (135,064) |  |  | (148,039) |
Depreciable property, plant and equipment, net | 34,553 |  |  | 53,347 |
Construction-in-progress | 2,250 |  |  | 7,163 |
Property, plant and equipment, net | $ | 36,803 |  |  | $ | 60,510 |

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -URI https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration